{"altmetric_id": 94063148, "counts": {"readers": {"citeulike": "0", "mendeley": "47", "connotea": "0"}, "news": {"unique_users_count": 17, "unique_users": ["business_wire", "digital_journal", "dmn_newswire", "morning_star", "crwe_world", "finanz_nachrichten", "stockwatch", "biospace", "the_daily_times", "marketscreener", "jotup", "wall_street_online_denmark", "it_business_net", "fierce_biotech", "end_points", "trialsite_news", "the_arizona_republic"], "posts_count": 17}, "total": {"posts_count": 196}, "twitter": {"unique_users_count": 66, "posts_count": 179}}, "citation": {"altmetric_jid": "medrxiv", "authors": ["Temesgen, Zelalem", "Assi, Mariam", "Vergidis, Paschalis", "Rizza, Stacey A.", "Bauer, Philippe R.", "Pickering, Brian W.", "Razonable, Raymund R.", "Libertin, Claudia R.", "Burger, Charles D.", "Orenstein, Robert", "Vargas, Hugo E.", "Varatharaj Palraj, Bharath Raj", "Dababneh, Ala S.", "Chappell, Gabrielle", "Chappell, Dale", "Ahmed, Omar", "Sakemura, Reona", "Durrant, Cameron", "Kenderian, Saad S.", "Badley, Andrew"], "doi": "10.1101/2020.06.08.20125369", "first_seen_on": "2020-11-11T03:41:53+00:00", "issns": [], "last_mentioned_on": 1618993752, "links": ["https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1#disqus_thread", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1.full.pdf", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1?rss=1%22", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v2", "http://www.medrxiv.org/content/10.1101/2020.06.08.20125369v1", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v2.full.pdf", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v2.full", "https://europepmc.org/article/med/32587983", "https://www.medrxiv.org/content/10.1101/2020.06.08.20125369v2#disqus_thread"], "pdf_url": "https://www.medrxiv.org/content/medrxiv/early/2020/06/12/2020.06.08.20125369.full.pdf", "pmid": "32587983", "publisher": "Cold Spring Harbor Laboratory", "title": "First Clinical Use of Lenzilumab to Neutralize GM-CSF in Patients with Severe COVID-19 Pneumonia", "type": "article", "mendeley_url": "https://www.mendeley.com/catalogue/bbb07e49-038f-3af1-bfbb-6af72f431819/"}, "altmetric_score": {"score": 156.7, "score_history": {"1y": 156.7, "6m": 5.55, "3m": 4.55, "1m": 2.7, "1w": 0, "6d": 0, "5d": 0, "4d": 0, "3d": 0, "2d": 0, "1d": 0, "at": 156.7}, "context_for_score": {"all": {"total_number_of_other_articles": 17575102, "mean": 9.4134159747134, "rank": 145304, "this_scored_higher_than_pct": 99, "this_scored_higher_than": 17432509, "rank_type": "exact", "sample_size": 17575102, "percentile": 99}, "similar_age_3m": {"total_number_of_other_articles": 382913, "mean": 16.430650309599, "rank": 6129, "this_scored_higher_than_pct": 98, "this_scored_higher_than": 376798, "rank_type": "exact", "sample_size": 382913, "percentile": 98}, "this_journal": {"total_number_of_other_articles": 19516, "mean": 54.780773211724, "rank": 1064, "this_scored_higher_than_pct": 94, "this_scored_higher_than": 18453, "rank_type": "exact", "sample_size": 19516, "percentile": 94}, "similar_age_this_journal_3m": {"total_number_of_other_articles": 2140, "mean": 65.11609906542, "rank": 155, "this_scored_higher_than_pct": 92, "this_scored_higher_than": 1986, "rank_type": "exact", "sample_size": 2140, "percentile": 92}}}, "demographics": {"poster_types": {"member_of_the_public": 57, "researcher": 3, "practitioner": 5}, "users": {"twitter": {"cohorts": {"Members of the public": 57, "Practitioners (doctors, other healthcare professionals)": 5, "Scientists": 3}}, "mendeley": {"by_status": {"Professor > Associate Professor": 4, "Researcher": 5, "Student  > Master": 7, "Student  > Ph. D. Student": 2, "Student  > Bachelor": 11, "Lecturer": 2, "Other": 5, "Librarian": 2}, "by_discipline": {"Materials Science": 1, "Medicine and Dentistry": 19, "Economics, Econometrics and Finance": 1, "Immunology and Microbiology": 3, "Nursing and Health Professions": 3, "Mathematics": 1, "Biochemistry, Genetics and Molecular Biology": 4, "Environmental Science": 1, "Pharmacology, Toxicology and Pharmaceutical Science": 1, "Chemical Engineering": 1, "Veterinary Science and Veterinary Medicine": 1}}}, "geo": {"twitter": {"US": 10, "AR": 1, "KM": 1, "ES": 2, "FR": 2, "CH": 1, "CA": 2, "JP": 2, "GB": 1}}}, "posts": {"twitter": [{"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "921400462838042624"}, "tweet_id": "1271483180365864961"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "208789709"}, "tweet_id": "1271499043953311745"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1059448511140388867"}, "tweet_id": "1271553162789478400"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "996014993903685632"}, "tweet_id": "1271554474960539649"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "929406448446173184"}, "tweet_id": "1271554865140060160"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1108856479002624002"}, "tweet_id": "1271584064915431424"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271599390579478529"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271599480077508610"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271600208430993417"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271606155542966273"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1105197891805724673"}, "tweet_id": "1271607941238591488"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1268166228759113729"}, "tweet_id": "1271611148752674817"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271629690218754048"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271638364135944193"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271638987481001984"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271639004883169280"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271640423786823681"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271648303894138881"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271648402296786944"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271648559218274305"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271648726713610241"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271648939545186305"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271662733205766145"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271662997987983360"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271663116779020288"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271675374527799299"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "745027622"}, "tweet_id": "1271704729807212547"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1271709606616547328"}, {"license": "gnip", "citation_ids": [80889938, 94063148], "author": {"tweeter_id": "1332366541"}, "tweet_id": "1271732908689063936"}, {"license": "gnip", "citation_ids": [80889938, 94063148], "author": {"tweeter_id": "929406448446173184"}, "tweet_id": "1271736912194293760"}, {"license": "gnip", "citation_ids": [80889938, 94063148], "author": {"tweeter_id": "952247125185720320"}, "tweet_id": "1271736920310243329"}, {"license": "gnip", "citation_ids": [80889938, 94063148], "author": {"tweeter_id": "2901400436"}, "tweet_id": "1271737100984029186"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1254141493780066305"}, "tweet_id": "1271760834516172800"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "417000528"}, "tweet_id": "1271762943793942534"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "956549078"}, "tweet_id": "1271767645482897408"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1216056743765127168"}, "tweet_id": "1271769107868848133"}, {"license": "gnip", "citation_ids": [80889938, 94063148], "author": {"tweeter_id": "450914677"}, "tweet_id": "1271786479484899329"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "41413588"}, "tweet_id": "1271809046052552706"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "135743430"}, "tweet_id": "1271810743692742657"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "736655937847459840"}, "tweet_id": "1271824024969129985"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "597480797"}, "tweet_id": "1271837194064474113"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271871217818091526"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271871275842056192"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271871768412794880"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271872232806121477"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "929406448446173184"}, "tweet_id": "1271886475769131012"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1253350259046051840"}, "tweet_id": "1271914970419085312"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271936193211572224"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1271999353444597762"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1244711417657376768"}, "tweet_id": "1272003943837638656"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1252917556534370304"}, "tweet_id": "1272147792547377152"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272187506155556864"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1124297736294150144"}, "tweet_id": "1272250938867306496"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1265336030833422337"}, "tweet_id": "1272283803390636032"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272330327181217792"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272330699970879489"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272330828681535488"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272330900471271425"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272330975297581056"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331065479385094"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331126934306817"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331375409090568"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331558058409992"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331651704651779"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331692146114560"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272331759766683648"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332488711471104"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332538145619968"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332593690746882"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332635029807110"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332664452911105"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332704286150659"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332935782453248"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272332988408303623"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333124513513474"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333247553339392"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333352012578816"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333410351173632"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333461014142978"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272333642065477634"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272339683280850944"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272345866897108993"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272345924891787266"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272346290521886720"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272346452925300738"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272346671096217601"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272346864151597058"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "218107857"}, "tweet_id": "1272353111684706305"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1272387717372891137"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1272408216626839552"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "587647947"}, "tweet_id": "1272410010648227840"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1271336113756614656"}, "tweet_id": "1272445043811454976"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272453846477004816"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272454156767412225"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272467732626321409"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "952247125185720320"}, "tweet_id": "1272500040842514436"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1205237684827934720"}, "tweet_id": "1272513852693938177"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1247376635004936192"}, "tweet_id": "1272516756381339649"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1010534825436909568"}, "tweet_id": "1272525093566951424"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "733717446"}, "tweet_id": "1272528971603652608"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3155271593"}, "tweet_id": "1272587969040449536"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "18026170"}, "tweet_id": "1272589695378059265"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272595057267408902"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1272598033679519744"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "167542916"}, "tweet_id": "1272620897350881281"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1272632236794208257"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1026696670791249920"}, "tweet_id": "1272692891387912192"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1252092008522375169"}, "tweet_id": "1272791850588332033"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "286508347"}, "tweet_id": "1272794796290002944"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "275818538"}, "tweet_id": "1272802560231870464"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3239482748"}, "tweet_id": "1273080274755215362"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1273402111049338880"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1273411071009632256"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1273439966438154242"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1273667895709458433"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "70490652"}, "tweet_id": "1274088547113459712"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "763814517289648129"}, "tweet_id": "1274453511720390657"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "26924020"}, "tweet_id": "1274532116605202432"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1274859563540336640"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2863961153"}, "tweet_id": "1274882707672248320"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1275780464410755072"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3109094919"}, "tweet_id": "1275794847601963009"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1276222750374260736"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1278076677847801856"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1278080782481756161"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1278200701680668672"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1278868710841651200"}, {"license": "gnip", "citation_ids": [84166013, 80873659, 94063148, 84860357, 84562891], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1280392940087463936"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1281272706864824320"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1136370591517290496"}, "tweet_id": "1281273886835949568"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1281728732747534336"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1281729451404005376"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "733717446"}, "tweet_id": "1281794604740698119"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "733717446"}, "tweet_id": "1281794847930630144"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1282109555988627456"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1282510282523242496"}, {"license": "gnip", "citation_ids": [94063148, 85251075], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1282662814109310977"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1282663361130442752"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1282663686486855680"}, {"license": "gnip", "citation_ids": [94063148, 85251075], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1282664109448859648"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2751153061"}, "tweet_id": "1282693716575215618"}, {"license": "gnip", "citation_ids": [94063148, 85251075], "author": {"tweeter_id": "733717446"}, "tweet_id": "1282734838227689472"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "788848143009841152"}, "tweet_id": "1282912370407256064"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "251826109"}, "tweet_id": "1283557931938648064"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1283738720517136384"}, {"license": "gnip", "citation_ids": [86141379, 94063148], "author": {"tweeter_id": "1054794218173022208"}, "tweet_id": "1285281751124901891"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "19269804"}, "tweet_id": "1303765150621720581"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1223307253236817922"}, "tweet_id": "1303801652978356224"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1223307253236817922"}, "tweet_id": "1303801678739787779"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1223307253236817922"}, "tweet_id": "1307336792715259904"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1268896288592080898"}, "tweet_id": "1309067197587886080"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1309073456512806916"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1268896288592080898"}, "tweet_id": "1309122554167275521"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1309122809646415874"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1268896288592080898"}, "tweet_id": "1309124861189652484"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1309160103426260998"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1309833835408953346"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1312160449446641664"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1312160706205155329"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "824162165561114624"}, "tweet_id": "1312161281059688448"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1312162715528437760"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1312163155489898496"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "722970901516427264"}, "tweet_id": "1312195360899563520"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "28610422"}, "tweet_id": "1312242167839109121"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3152812527"}, "tweet_id": "1312336814594838528"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3152812527"}, "tweet_id": "1312390200006529025"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1323234176708104200"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1323269496719790090"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1348501004665368577"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1359986509798072324"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2982079961"}, "tweet_id": "1372258265929809929"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3152812527"}, "tweet_id": "1372267923176361994"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1384464959380221953"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "3294485143"}, "tweet_id": "1384465392526106625"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "2412186234"}, "tweet_id": "1384468736275632128"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1244222636756029440"}, "tweet_id": "1384475394565238788"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "1348803690191351811"}, "tweet_id": "1384514236018270208"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "770050367799296001"}, "tweet_id": "1384537631099396103"}, {"license": "gnip", "citation_ids": [94063148], "author": {"tweeter_id": "88589013"}, "tweet_id": "1384786284124778496"}], "news": [{"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42374985972&p=1pl&v=1&x=_LqQ0s0CWpHhskr7qclqUA", "license": "public", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564, 76409023, 51799512], "posted_on": "2020-06-16T11:00:00+00:00", "summary": "Lenzilumab median time to recovery of five days compares favorably to remdesivir\u2019s 10 days in a similar patient group Lenzilumab Phase 3 potential registration study ongoing in severe and critical COVID-19 patients Humanigen to host a webinar today\u2026", "author": {"name": "Business Wire", "url": "http://www.businesswire.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/867/normal/Screen_Shot_2016-01-27_at_12.24.36.png?1453897504"}}, {"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42374973105&p=1pl&v=1&x=fc6xmtZOSF4nwAfRP-jEqg", "license": "public", "citation_ids": [74464078, 82566104, 82901564, 51799512, 76409023, 76409023, 94063148, 94063148], "posted_on": "2020-06-16T11:08:54+00:00", "summary": "BURLINGAME, Calif.--(Business Wire)-- Humanigen, Inc., (HGEN) (\u201cHumanigen\u201d), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company\u2019s proprietary Humaneered \u00ae anti-human granulocyte\u2026", "author": {"name": "Digital Journal", "url": "http://www.digitaljournal.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/000/223/normal/image.png?1371424893"}}, {"title": "Mayo Clinic Study of Humanigen\u2019s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42366984404&p=1pl&v=1&x=6qURGZI7MOFiDWhy5nC1LQ", "license": "public", "citation_ids": [76409023, 74464078, 76409023, 82566104, 82901564, 94063148, 51799512, 94063148], "posted_on": "2020-06-15T11:02:39+00:00", "summary": "Median time to recovery and discharge of five days All patients were at high risk of progression, including four patients who were in the ICU prior to receiving lenzilumab No treatment emergent adverse events were attributable to lenzilumab\u2026", "author": {"name": "DMN Newswire!", "url": "http://dmnnewswire.digitalmedianet.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/925/normal/Screen_Shot_2018-09-17_at_18.46.43.png?1537206495"}}, {"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42374941302&p=1pl&v=1&x=YalP0K6RrdN80d9CfNivDA", "license": "public", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564, 76409023, 51799512], "posted_on": "2020-06-16T11:00:00+00:00", "summary": "Lenzilumab median time to recovery of five days compares favorably to remdesivir's 10 days in a similar patient group Lenzilumab Phase 3 potential registration study ongoing in severe and critical COVID-19 patients Humanigen to host a webinar today\u2026", "author": {"name": "Morning Star", "url": "https://www.morningstar.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/912/normal/Screen_Shot_2018-09-17_at_18.20.59.png?1537204915"}}, {"title": "Mayo Clinic Study of Humanigen\u2019s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42367016636&p=1pl&v=1&x=bCsuBjazLl48vXN2YAKxaA", "license": "public", "citation_ids": [76409023, 74464078, 76409023, 94063148, 82566104, 82901564, 51799512, 94063148], "posted_on": "2020-06-15T11:09:24+00:00", "summary": "11:00 UTC Median time to recovery and discharge of five days All patients were at high risk of progression, including four patients who were in the ICU prior to receiving lenzilumab No treatment emergent adverse events were attributable to\u2026", "author": {"name": "Crwe World", "url": "http://crweworld.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/344/normal/Capture_crwe.PNG?1574923200"}}, {"title": "News story from Finanz Nachrichten on Tuesday 16 June 2020", "url": null, "license": "nla", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564, 76409023, 51799512, 94063148], "posted_on": "2020-06-16T11:08:00+00:00", "summary": null, "author": {"name": "Finanz Nachrichten", "url": "http://www.finanznachrichten.de", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/853/normal/Screen_Shot_2016-01-27_at_11.54.22.png?1453895724"}}, {"title": "Mayo Clinic Study of Humanigen's Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42367047393&p=1pl&v=1&x=-2wkrV8tlGGlfET_IlfCxQ", "license": "public", "citation_ids": [76409023, 74464078, 76409023, 94063148, 82566104, 82901564, 51799512, 94063148], "posted_on": "2020-06-15T11:13:35+00:00", "summary": "Median time to recovery and discharge of five days All patients were at high risk of progression, including four patients who were in the ICU prior to receiving lenzilumab No treatment emergent adverse events were attributable to lenzilumab\u2026", "author": {"name": "Stockwatch", "url": "https://www.stockwatch.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/797/normal/Capture19.PNG?1576480973"}}, {"title": "Mayo Clinic Study of Humanigen\u2019s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42367191909&p=1pl&v=1&x=Z0cjrK-LrYlhe2iks4Bmvg", "license": "public", "citation_ids": [74464078, 76409023, 76409023, 94063148, 82566104, 82901564, 51799512, 94063148], "posted_on": "2020-06-15T11:35:48+00:00", "summary": "11:00 UTC Median time to recovery and discharge of five days All patients were at high risk of progression, including four patients who were in the ICU prior to receiving lenzilumab No treatment emergent adverse events were attributable to\u2026", "author": {"name": "Biospace", "url": "http://www.biospace.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/375/normal/biospace.png?1437140433"}}, {"title": "Mayo Clinic Study of Humanigen\u2019s Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42367195974&p=1pl&v=1&x=r0LG6Fj9GlOo5Lmjw88bqg", "license": "public", "citation_ids": [76409023, 74464078, 76409023, 94063148, 82566104, 82901564, 51799512, 94063148], "posted_on": "2020-06-15T11:01:42+00:00", "summary": "- Humanigen, Inc., (HGEN) (\u201cHumanigen\u201d), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company\u2019s proprietary Humaneered \u00ae anti-human granulocyte macrophage-colony stimulating\u2026", "author": {"name": "The Daily Times", "url": "https://www.thedailytimes.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/837/normal/Capture5.PNG?1576556700"}}, {"title": "HUMANIGEN : Mayo Clinic Study of Humanigen's Lenzilumab Shows Rapid Recovery and Discharge in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42375372495&p=1pl&v=1&x=cjJ5VCc7p_k26RnwRbs8Sg", "license": "public", "citation_ids": [74464078, 76409023, 76409023, 94063148, 82566104, 82901564, 51799512, 94063148], "posted_on": "2020-06-16T12:06:50+00:00", "summary": "Burlingame, CA - Humanigen, Inc., (HGEN) (' Humanigen '), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company's proprietary Humaneered anti-human granulocyte macrophage-colony\u2026", "author": {"name": "MarketScreener", "url": "https://www.marketscreener.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/689/normal/screen.PNG?1576146564"}}, {"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42375535699&p=1pl&v=1&x=2-SH03PkLQquiVxMi_moCg", "license": "public", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564, 76409023, 51799512, 94063148], "posted_on": "2020-06-16T12:30:02+00:00", "summary": "Nevertheless, this secondary analysis was conducted to provide context for the data generated to date with lenzilumab.", "author": {"name": "Jotup", "url": "https://jotup.co/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/231/normal/jotup-logo.png?1567071493"}}, {"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42374986281&p=1pl&v=1&x=LPtPMSieLcI5ulHBsI0aXg", "license": "public", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564], "posted_on": "2020-06-16T11:00:00+00:00", "summary": ", (HGEN) (\u201cHumanigen\u201d), a clinical stage biopharmaceutical company focused on preventing and treating cytokine storm with lenzilumab, the company\u2019s proprietary Humaneered anti-human granulocyte macrophage-colony stimulating factor (GM-CSF\u2026", "author": {"name": "Wall Street Online Denmark", "url": "http://www.wallstreet-online.de", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/836/normal/Screen_Shot_2016-01-27_at_11.09.05.png?1453892964"}}, {"title": "Humanigen Reports Additional Analysis of Lenzilumab in Severe and Critical COVID-19 Patients", "url": "http://ct.moreover.com/?a=42375562916&p=1pl&v=1&x=j2JLc8lp3lEbzA0Lui1hHA", "license": "public", "citation_ids": [94063148, 76409023, 74464078, 82566104, 82901564, 76409023, 51799512], "posted_on": "2020-06-16T12:11:39+00:00", "summary": "@media screen and (min-width:1201px){.lmtmg5ee8bc225f901{display:block}}@media screen and (min-width:993px) and (max-width:1200px){.lmtmg5ee8bc225f901{display:block}}@media screen and (min-width:769px) and (max-width:992px){.lmtmg5ee8bc225f901{display\u2026", "author": {"name": "IT Business Net", "url": "http://www.itbusinessnet.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/004/627/normal/Capture_it_bussiness.PNG?1576063357"}}, {"title": "A drug from Shkreli's former company Humanigen shows early promise in COVID-19", "url": "https://www.fiercebiotech.com/research/drug-by-martin-shkreli-s-former-company-humanigen-shows-early-promise-covid-19", "license": "public", "citation_ids": [94063148, 79988414], "posted_on": "2020-06-17T10:59:57+00:00", "summary": "Although infection with the novel coronavirus can lead to severe pneumonia, most deaths associated with COVID-19 are caused by a complication called \"cytokine storm,\" an immune overreaction marked by the activation and release of large numbers of\u2026", "author": {"name": "Fierce Biotech", "url": "http://www.fiercebiotech.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/002/239/normal/Screen_Shot_2016-02-25_at_15.13.22.png?1456413240"}}, {"title": "Covid-19 roundup: Novavax recruits AstraZeneca vet as its new CMO \u2014 right after David Mott jumps on the board; ...", "url": "http://ct.moreover.com/?a=42385777080&p=1pl&v=1&x=_9BpmhOEvbgLqRfORJNhwA", "license": "public", "citation_ids": [94063148], "posted_on": "2020-06-17T11:15:14+00:00", "summary": "Jason Mast Associate Editor John Carroll Editor & Founder One of the dark-horse con\u00adtenders in a race to the fin\u00adish line with a new vac\u00adcine for Covid-19 has just wooed a se\u00adnior As\u00adtraZeneca re\u00adsearcher to the fold as its new chief med\u00adical of\u00adfi\u00adce\u2026", "author": {"name": "End Points", "url": "https://endpts.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/369/normal/Screenshot_2019-09-19_at_09.40.31.png?1568882479"}}, {"title": "Stakes Get Bigger as Patient Health and Success of Humanigen Platform Depend on Evidence from COVID-19 Clinical Trials", "url": "https://www.trialsitenews.com/stakes-get-bigger-as-patient-health-and-success-of-humanigen-platform-depend-on-evidence-from-covid-19-clinical-trials/", "license": "public", "citation_ids": [4276401, 4469477, 14360865, 51799512, 94063148, 79988414], "posted_on": "2020-06-17T17:00:28+00:00", "summary": "San Francisco Bay Area biotech venture Humanigen, Inc. (HGEN), formerly known as KaloBios Pharmaceuticals, is a clinical stage company focused on preventing and treating cytokine storm with lenzilumab, their proprietary Humaneered\u00ae anti-human\u2026", "author": {"name": "TrialSite News", "url": "https://www.trialsitenews.com", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/110/normal/Screenshot_2019-07-12_at_12.25.34.png?1562930787"}}, {"title": "Could one of these drugs be the next emergency treatment for COVID-19?", "url": "http://ct.moreover.com/?a=42830027355&p=1pl&v=1&x=vowtldI-Ni9Qd834jxvsxQ", "license": "public", "citation_ids": [94063148, 85108630, 94048272], "posted_on": "2020-08-13T15:00:18+00:00", "summary": "Cameron Durrant, the CEO of drugmaker Humanigen, says his company's anti-inflammatory drug lenzilumab is different from other treatments being tested against COVID-19.", "author": {"name": "The Arizona Republic", "url": "http://www.azcentral.com/", "image": "https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/001/426/normal/Screen_Shot_2016-01-06_at_11.54.25.png?1452081306"}}]}, "score": 156.7, "images": {"small": "https://badges.altmetric.com/?size=64&score=157&types=mttttttt", "medium": "https://badges.altmetric.com/?size=100&score=157&types=mttttttt", "large": "https://badges.altmetric.com/?size=180&score=157&types=mttttttt"}}